Advertisement
Screener

ALPHATEC HOLDINGS, INC. (ATEC) Business Acquisition, Pro Forma Net Income (Loss)

3.3 / 5 stars · 52/80 Roast Me

ALPHATEC HOLDINGS, INC. Business Acquisition, Pro Forma Net Income (Loss)

ALPHATEC HOLDINGS, INC. (ATEC) reported Business Acquisition, Pro Forma Net Income (Loss) of -$28.98 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-29.

Discontinued › Expense Statement › Operating Expenses

us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss · last filed 2019-03-29

  • ALPHATEC HOLDINGS, INC. business acquisition, pro forma net income (loss) for the quarter ending 2018-12-31 was -$9.91M, a 223.82% decline year-over-year.
  • ALPHATEC HOLDINGS, INC. business acquisition, pro forma net income (loss) for the quarter ending 2018-09-30 was -$9.53M.
  • ALPHATEC HOLDINGS, INC. business acquisition, pro forma net income (loss) for the quarter ending 2018-06-30 was -$6.80M.
  • ALPHATEC HOLDINGS, INC. business acquisition, pro forma net income (loss) for the quarter ending 2018-03-31 was -$2.74M.
  • ALPHATEC HOLDINGS, INC. business acquisition, pro forma net income (loss) for fiscal 2018 was -$28.98M.
  • ALPHATEC HOLDINGS, INC. business acquisition, pro forma net income (loss) for fiscal 2017 was -$6.53M.
Period endBusiness Acquisition, Pro Forma Net Income (Loss) 3 monthBusiness Acquisition, Pro Forma Net Income (Loss) 6 monthBusiness Acquisition, Pro Forma Net Income (Loss) 9 monthBusiness Acquisition, Pro Forma Net Income (Loss) 12 month
2018-12-31-$9.91M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29
-$19.43M
derived: sum of 2 quarters · filed 2019-03-29
-$26.23M
derived: sum of 3 quarters · filed 2019-03-29
-$28.98M
10-K · filed 2019-03-29
2018-09-30-$9.53M
10-Q · filed 2018-11-09
-$16.32M
derived: sum of 2 quarters · filed 2018-11-09
-$19.07M
10-Q · filed 2018-11-09
-$11.07M
derived: sum of 4 quarters · filed 2019-03-29
2018-06-30-$6.80M
10-Q · filed 2018-08-03
-$9.54M
10-Q · filed 2018-08-03
-$1.54M
derived: sum of 3 quarters · filed 2019-03-29
-$5.68M
derived: sum of 4 quarters · filed 2019-03-29
2018-03-31-$2.74M
10-Q · filed 2018-05-11
$5.26M
derived: sum of 2 quarters · filed 2019-03-29
$1.11M
derived: sum of 3 quarters · filed 2019-03-29
-$2.53M
derived: sum of 4 quarters · filed 2019-03-29
2017-12-31$8.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29
$3.86M
derived: sum of 2 quarters · filed 2019-03-29
$217.00K
derived: sum of 3 quarters · filed 2019-03-29
-$6.53M
10-K · filed 2019-03-29
2017-09-30-$4.14M
10-Q · filed 2018-11-09
-$7.78M
derived: sum of 2 quarters · filed 2018-11-09
-$14.53M
10-Q · filed 2018-11-09
2017-06-30-$3.64M
10-Q · filed 2018-08-03
-$10.39M
10-Q · filed 2018-08-03
2017-03-31-$6.75M
10-Q · filed 2018-05-11

Similar stocks

Stock NameCountryMarket CapPE Ratio
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)United States$1.535B-9.02
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)United States$1.234B-193.02
LEMAITRE VASCULAR INC (LMAT)United States$1.848B33.37
NovoCure Ltd (NVCR)$1.886B-11.87
ARTIVION, INC. (AORT)United States$1.123B-345.09
IRADIMED CORP (IRMD)United States$1.089B52.92
Inspire Medical Systems, Inc. (INSP)United States$1.990B9.55
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57
PROCEPT BioRobotics Corp (PRCT)United States$1.001B-11.77
Beta Bionics, Inc. (BBNX)United States$0.979B-9.66